ATOSSA THERAPEUTICS, INC.

ATOS

ATOSSA THERAPEUTICS, INC.

ATOS

Insider Sentiment (TTM):

Last Purchase:2025-05-21Last Sale:2023-11-15Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,238,775Shares Outstanding:8,622,289Institutional Ownership Pct.:14.37%

Earnings Market Reaction:

Filing Date:2026-05-08Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	32	41	52	58	65	71	75	80	84	88	94	99
Restricted Cash And Cash Equivalents At Carrying V…	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense Current	-	-	-	-	-	-	-	-	-	-	3	6
Assets Current
Assets Current	37	46	56	63	69	74	77	82	87	92	98	106
Other Assets Current	-	-	-	-	-	-	-	-	-	-	0	0
Prepaid Expense And Other Assets Current	2	1	1	1	1	1	1	1	2	2	-	-
Other Assets Noncurrent	1	2	2	2	2	2	2	2	2	2	2	1
Equity Securities Without Readily Determinable Fai…	-	-	-	-	-	0	0	2	2	2	2	2
Assets	38	48	58	65	71	76	79	86	91	96	102	108
Liabilities And Stockhold…
Accounts Payable Current	3	4	4	2	1	1	2	1	1	1	1	1
Accrued Liabilities Current	3	1	2	2	2	1	2	2	2	1	1	1
Liabilities Current
Liabilities Current	7	8	8	7	5	5	6	6	5	5	3	3
Employee Related Liabilities Current	1	2	1	1	1	2	1	1	1	2	1	1
Other Liabilities Current	1	1	2	2	2	2	1	2	2	2	0	0
Liabilities	7	8	8	7	5	5	6	6	5	5	3	3
Preferred Stock Value	0	-	0	0	0	0	0	0	0	0	0	0
Common Stock Value	2	2	23	23	23	2	23	23	23	23	23	23
Stockholders Equity
Stockholders Equity	30	39	50	58	65	71	74	80	86	91	98	105
Additional Paid In Capital Common Stock	-	-	-	-	-	-	-	-	-	-	255	254
Additional Paid In Capital	287	286	263	263	262	283	258	257	257	256	-	-
Treasury Stock Common Value	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-0
Retained Earnings Accumulated Deficit	-256	-247	-236	-227	-219	-212	-205	-198	-192	-186	-179	-172
Liabilities And Stockholders Equity	38	48	58	65	71	76	79	86	91	96	102	108
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	-	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	-	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.18	0.18	0.18	0.18	0.18	0.18	0.18	0.18	0.18	0.18	0.18	0.18
Common Stock Shares Authorized	350	350	350	350	350	350	350	350	350	350	350	350
Common Stock Shares Issued	9	9	9	9	9	1	1	1	1	1	1	1
Shares Outstanding	9	9	9	9	9	9	8	8	8	8	8	8
Treasury Stock Common Shares	0	0	1	1	1	0	1	1	1	1	1	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-6.61%	-66.43%	-58.93%	-	-	-	-	-	-	-	-	-
2025	1.12%	-4.49%	-7.87%	2.60%	31.17%	15.58%	-1.23%	-22.22%	-29.63%	7.56%	-10.52%	-54.61%
2024	-14.38%	-25.34%	-16.44%	7.26%	18.55%	14.52%	-18.67%	-32.67%	-44.00%	-13.89%	34.72%	15.28%
2023	23.94%	67.61%	49.30%	-13.54%	-25.00%	-27.08%	19.05%	47.62%	34.92%	-23.50%	-27.00%	-43.50%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	4.92	5.53	6.77	9.17	12.67	14.99	13.30	14.35	16.34	17.61	28.35	30.48
Quick Ratio	4.67	5.39	6.70	9.01	12.41	14.76	13.14	14.17	16.04	17.20	27.34	28.82
Working Capital	29.21M	37.36M	47.45M	55.70M	63.32M	69.49M	71.32M	76.02M	81.73M	86.98M	94.20M	102.53M
Leverage & Debt
Debt to Equity	0.24	0.21	0.17	0.12	0.08	0.07	0.08	0.07	0.06	0.06	0.04	0.03
Debt Ratio	0.20	0.17	0.14	0.11	0.08	0.06	0.07	0.07	0.06	0.05	0.03	0.03
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-4.37	-4.04	-3.50	-3.33	-3.06	-3.04	-3.21	-3.09	-3.55	-3.58	-3.56	-3.74
Free Cash Flow Per Share TTM	-3.87	-3.46	-3.05	-2.91	-2.59	-2.51	-2.33	-2.23	-2.23	-2.49	-2.37	-2.54
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	42.88%	36.33%	12.15%	10.84%	-11.27%	-15.25%	-9.79%	-18.04%	4.34%	11.62%	22.76%	47.13%
EPS Growth (1Y)	42.88%	32.84%	9.20%	7.89%	-14.03%	-15.10%	-9.77%	-17.46%	5.43%	12.10%	23.57%	47.13%
Valuation Metrics
P/E TTM	-1.20	-2.19	-3.72	-3.73	-3.29	-4.64	-7.10	-5.77	-7.60	-3.69	-3.12	-5.05
P/B TTM	1.49	1.94	2.26	1.86	1.33	1.66	2.59	1.87	2.63	1.22	0.95	1.52
Market Cap	45.35M	76.21M	112.38M	107.21M	86.65M	118.31M	191.17M	149.62M	225.58M	110.95M	93.09M	159.54M
Enterprise Value	13.64M	34.91M	60.53M	49.35M	21.54M	47.22M	116.41M	70.10M	141.62M	22.49M	-944.09K	60.15M
Calculated Values
Free Cash Flow TTM	-33.40M	-29.79M	-26.29M	-25.04M	-22.31M	-21.05M	-19.57M	-18.69M	-18.64M	-20.96M	-19.92M	-21.45M
Net Debt	-31.72M	-41.30M	-51.85M	-57.86M	-65.12M	-71.08M	-74.77M	-79.53M	-83.96M	-88.46M	-94.03M	-99.39M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-05-21Purchase

Owner: Quay, Steven C

Title: President & CEO

Shares: 11,239

Price/Share: $0.88

Value: $9,890.32

Shares Owned: 13,898

Relationship: Director,Officer

Ownership: Direct

2025-03-26Purchase

Owner: Remmel, H. Lawrence

Title: -

Shares: 10,000

Price/Share: $0.70

Value: $7,000.00

Shares Owned: 10,257

Relationship: Director

Ownership: Direct

2024-04-10Purchase

Owner: Finn, Jonathan

Title: -

Shares: 25,000

Price/Share: $1.77

Value: $44,250.00

Shares Owned: 25,000

Relationship: Director

Ownership: Direct

2023-11-15Sale

Owner: Weaver, Gregory L

Title: Former EVP, CFO, & Director

Shares: 50,000

Price/Share: $0.65

Value: $32,500.00

Shares Owned: 55

Relationship: Director,Officer

Ownership: Direct

2023-06-20Purchase

Owner: Weaver, Gregory L

Title: EVP & CFO

Shares: 50,000

Price/Share: $0.97

Value: $48,500.00

Shares Owned: 50,055

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-05-21	Quay, Steven C	Director,Officer	President & CEO	Direct	Purchase	11,239	0.88	$9,890.32	13,898	4
2025-03-26	Remmel, H. Lawrence	Director	-	Direct	Purchase	10,000	0.70	$7,000.00	10,257	4
2024-04-10	Finn, Jonathan	Director	-	Direct	Purchase	25,000	1.77	$44,250.00	25,000	4
2023-11-15	Weaver, Gregory L	Director,Officer	Former EVP, CFO, & Director	Direct	Sale	50,000	0.65	$32,500.00	55	4
2023-06-20	Weaver, Gregory L	Director,Officer	EVP & CFO	Direct	Purchase	50,000	0.97	$48,500.00	50,055	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

14.37%

Inst. Shares: 1,238,775

Shares Outstanding: 8,622,289

2025-12-31

16.91%

Inst. Shares: 1,456,032

Shares Outstanding: 8,611,321

2025-09-30

14.62%

Inst. Shares: 1,258,603

Shares Outstanding: 8,611,428

2025-06-30

16.30%

Inst. Shares: 1,403,357

Shares Outstanding: 8,611,362

2025-03-31

21.68%

Inst. Shares: 1,869,271

Shares Outstanding: 8,622,289

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,238,775	8,622,289	14.37%
2025-12-31	1,456,032	8,611,321	16.91%
2025-09-30	1,258,603	8,611,428	14.62%
2025-06-30	1,403,357	8,611,362	16.30%
2025-03-31	1,869,271	8,622,289	21.68%
2024-12-31	1,949,168	8,390,618	23.23%
2024-09-30	1,796,066	8,384,844	21.42%
2024-06-30	1,726,728	8,382,143	20.60%
2024-03-31	1,156,655	8,354,652	13.84%
2023-12-31	945,383	8,405,440	11.25%
2023-09-30	960,955	8,386,207	11.46%
2023-06-30	965,450	8,441,520	11.44%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ATOSSA THERAPEUTICS, INC. (ATOS) — SEC Financial Statements & Analysis

ATOSSA THERAPEUTICS, INC. (ATOS) is a pharmaceutical preparations company, incorporated in DE. ATOSSA THERAPEUTICS, INC. trades on Nasdaq as: ATOS. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ATOSSA THERAPEUTICS, INC. reported a Debt-to-Equity ratio of 0.24x, a Price-to-Book (P/B) ratio of 1.49 (TTM), at a market cap of $45.35M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.24x
P/B TTM: 1.49
Market Cap: $45.35M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ATOSSA THERAPEUTICS, INC. in?

ATOSSA THERAPEUTICS, INC. (ATOS) operates in the Pharmaceutical Preparations industry.

What is ATOS's market cap?

ATOSSA THERAPEUTICS, INC. (ATOS) has a market capitalization of $45.35M as of 2026-03-31.

What exchange does ATOS trade on?

ATOSSA THERAPEUTICS, INC. (ATOS) trades on the Nasdaq.

Where is ATOSSA THERAPEUTICS, INC. incorporated?

ATOSSA THERAPEUTICS, INC. is incorporated in DE.

ATOSSA THERAPEUTICS, INC. (ATOS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.